U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297186) titled 'Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)' on Dec. 09.
Brief Summary: The study aimed to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine in infants aged two months (60~89 days).
Study Start Date: Aug. 21, 2017
Study Type: INTERVENTIONAL
Condition:
Poliomyelitis
Intervention:
BIOLOGICAL: sIPV
sIPVs were developed by Biominhai (Beijing Minhai Biotechnology Co. Ltd.)
BIOLOGICAL: wIPV
wIPVs were developed by Sanofi Pasteur
Recruitment Status: COMPLETED
Sponsor: Beijing Minhai Biotechnology Co., Ltd
Published by HT Digital Content Services with...